Navigation Links
Taiwan Biophotonic Co. Receives CE Mark to Launch World's First Medical Smart Watch for Monitoring Heart Rate and Blood Oxygen

TAIPEI, Taiwan, Feb. 21, 2017 /PRNewswire/ -- Taiwan Biophotonic Co. (tBPC), a medical device company and the leading provider of non-invasive vital signs sensing solutions, today announced the CE Marking and the debut of the industry's first finger-free wrist pulse oximeter, the oCareTM Pro 100, which is a quantum leap forward in the wearable healthcare and medical devices space. 

tBPC's Wrist Pulse Oximeter, the oCareTM Pro 100, provides a non-invasive, simple and reliable method to measure and record heart rate and blood oxygen saturation on the wrist, without hindering wires and a fingertip probe that clamps on the finger. This device is designed to follow adult users for use in checking and/or recording of specific physiological parameters. These users may be in hospitals, hospital-type facilities, and a home environment. Professional users can upload timely data measured during daily activities or sleeping for physical or clinical evaluation.

Continue Reading
The Medical Smart Watch, oCare Pro is Built with tBPC's Patented DOE Lens Reflective PPG Sensor Which Measures Heart Rate and Blood Oxygen on the Wrist with Medical Grade Accuracy.
The Medical Smart Watch, oCare Pro is Built with tBPC's Patented DOE Lens Reflective PPG Sensor Which Measures Heart Rate and Blood Oxygen on the Wrist with Medical Grade Accuracy.

Pulse oximeters have been recognized as life-saving devices for patients with chronic respiratory disease such as OSA, COPD, CHF and asthma. OSA patients with breathing problems during sleep may encounter life-threatening situations at low blood oxygen levels. These patients rely on pulse oximeters to monitor their blood oxygen level and oxygen desaturation frequency/time during sleep. For COPD patients under oxygen therapy, oxygen is best prescribed to achieve a desirable target range rather than a fixed dose of oxygen. They may have hypoxia syndrome while their blood oxygen levels are lower than 85% or hypercapnia syndrome if their blood oxygen levels are higher than 95% caused by oversupply of oxygen. Continuous monitoring of blood oxygen levels in these patients has been studied to be effective in detecting and preventing respiratory failure, motivating physical activity and a healthy lifestyle to reduce the symptoms of chronic disease and its co-morbidities.

Current pulse oximeters use a clip-like probe that measures the heart rate and blood oxygen level from the fingertip, making it very inconvenient for continuous monitoring. The sensor probe will interfere with the movement of fingers. It may easily fall off from the finger during daily activities or sleep. Furthermore, the sensor probe will cause finger pain or thrombosis when the probe is clamped on the finger for hours.

tBPC's oCareTM Pro 100 is a medical smart watch, built with a DOE Lens Reflective PPG Sensor (oCareTM Sensor) mounted on the bottom of watchcase, making its application site the wrist skin. The DOE Lens Reflective PPG Sensor consists of two or more light emitting diodes (LEDs) and one or more photodiode light detectors (PDs) located side-by-side on a substrate. Light beams are shone from LEDs through the skin to the arteriolar bed of the tissue. The arteriolar bed absorbs variable amounts of light during the pulsations. Changes in light absorption during the pulsing cycle are measured by the PDs as scattered light that is reflected back from the pulsating arteriolar bed. The ratio of light absorbed is translated into a measurement of heart rate and functional oxygen saturation.

"Our oCareTM Sensor has high lighting efficiency and less power consumption than most common reflective PPG sensors, LED and photodiode components in the market. In the oCareTM Sensor, each LED die is separately encapsulated with a cannonball-shaped lens, and the photodiode is covered by an encapsulated layer with DOE (micro-structure) surface. These lenses will enhance the LED output radiant flux by more than 50-100%. The DOE will enhance the photodiode sensitivity by more than 10-50%. The innovative technologies of the oCareTM Sensor are fully protected by tBPC's patents including Taiwan Patent No. 1477759, China Patent No. ZL201310365671.3, U.S. Patent No. 9,506,802 B2, and other Taiwan, U.S.A. and foreign pending patents," said Dr. JC Chen, founder and President of tBPC.

The demands of today's healthcare solutions are revolutionary, varied, and challenging. Devices that were primarily found in hospitals are going to home healthcare, fitness monitoring and wellness applications. tBPC's oCareTM Pro 100 is poised to revolutionize healthcare, yielding significantly more insights into one's overall health status and performance than tracking heart rates alone. The blood oxygen level is actually another important vital sign which provides the health condition of both the cardiovascular and respiratory systems. tBPC's oCareTM Pro 100 can help users avoid life-threatening situations by checking heart rate and blood oxygen levels before starting exercise, and assist runners in maintaining healthy blood oxygen level at all times by helping them to work out properly and breathe thoroughly.

Key Features & Product Information

  • Measures heart rate and blood oxygen saturation directly on the wrist without connecting a cable or clamping a probe on the finger.
  • Smart watch with medical-grade accuracy and safety which compiles with related European Medical Devices Directives and US FDA Guidelines, and were validated by IRB regulated human clinical trials.
  • Easy-to-read 65K color OLED graphic display,
  • Built-in memory for up to 72 hours of data storage,
  • Peripheral micro-USB connector used as the battery charging port,
  • Built-in rechargeable lithium-ion polymer battery,
  • Warning alarms in response to abnormal conditions with lighting indicator and/or wrist vibration,
  • Communication via a wireless connection by a embedded Bluetooth module,
  • Multi-color interchangeable watchbands.

About Taiwan Biophotonic Co. (tBPC)

Funded in April 2014, tBPC targets itself to be the leading global biophotonic company with a full range of operations. tBPC has a team of expertise in the R&D, engineering, manufacturing, marketing and sales of life-sciences, healthcare and medical-related products and services. Headquartered at the Biomedical Industrial Park of Hsinchu County, Taiwan, tBPC's facility and quality management system have been certified by related regulatory authorities to comply with Taiwan FDA GMP, EU ISO 9001 and ISO 13485.

tBPC is dedicated to developing two mainstream technologies including Wearable Vital Signs Sensing Solutions and Non-invasive Glucose detection. The Wearable Vital Signs Sensing Solutions are used for measuring various physiological parameters for healthcare and medical care. In addition, tBPC has developed cutting-edge technologies that measure the glucose concentration in the aqueous humor of the eye by multi-modes optical detection without drawing blood samples from the finger. Currently tBPC's core technologies are protected by 9 awarded patents and 55 pending patents.

Additional information about Taiwan Biophotonic Corporation is available on the web at

Media Contact: JC Chen, Taiwan Biophotonic Co., Tel.: +886-3-667-0888, e-mail:

To view the original version on PR Newswire, visit:

SOURCE Taiwan Biophotonic Corporation
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN arbeitet mit Taiwan bei landesweitem Tuberkulose-Screening zusammen
2. QIAGEN Partners With Taiwan in Nationwide TB Screening Effort
3. TaiGen Biotechnology Launches Taigexyn(R) in Taiwan
4. PharmaEngine Announces Taiwan FDA Approval of ONIVYDE (TM) (irinotecan liposome injection) for the Treatment of Metastatic Pancreatic Cancer
5. Leading Cancer Clinic in Taiwan Replaces Paper Charts with An All-Electronic Clinical Process And Enhanced Patient Safety Features
6. PharmaEngine Announces Filing New Drug Application (NDA) of MM-398 (PEP02) to Taiwan FDA as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
7. TWi Biotechnology Receives Rare Disease Drug Designation for its Drug Candidate AC-203 in Taiwan
8. TWi Biotechnology Receives Approval of Protocol for Its Drug AC-201 Controlled-Release Tablet, Phase II Clinical Trial in Both the United States and Taiwan
9. License, Distribution and Supply Agreement to Market Cholecalciferol in China, Hong Kong, Macau and Taiwan
10. Vertrag über Lizenz, Distribution und Lieferung zur Vermarktung von Cholecalciferol in China, Hongkong, Macau und Taiwan
11. Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices
Post Your Comments:
(Date:9/22/2017)... Md. , Sept. 22, 2017  As the ... Republican Senators Bill Cassidy (R-LA) and ... Information notes that the medical device industry is in ... medical device tax, the 2.3% excise tax on medical ... But they also want covered patients, increased visits and ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/13/2017)... 2017   OrthoAtlanta has been named the official ... Committee (AFHC) for the 2018 College Football Playoff (CFP) National ... Mercedes-Benz Stadium in Atlanta, Georgia . OrthoAtlanta ... In" campaign, participating in many activities leading up to, and ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
Breaking Medicine News(10 mins):